All News

FDA clears novel psoriatic arthritis treatment

July 21, 2020

The drug is the first treatment approved for active psoriatic arthritis that selectively inhibits interleukin (IL)-23.

Express Scripts accused of overcharging millions of dollars

July 21, 2020

The PBM overcharged for generic drugs, among other offenses, a new lawsuit claims.

Sandoz to supply critical generic injectable meds

July 14, 2020

The pharma maker is partnering with the nonprofit Civica Rx to help reduce shortages in hospitals.

Another pharma maker recalls metformin over NDMA

July 13, 2020

Five other manufacturers have recalled the popular diabetes medication due to the presence of a the carcinogenic ingredient.

Popular HIV-1 med successful, particularly in order adults

July 07, 2020

Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.

FDA clears first-in-class HIV-1 treatment

July 06, 2020

Drug helps with heavily-treatment experienced (HTE) adults with multidrug-resistant HIV-1 infection.

U.S. government secures remdesivir supply for COVID-19 patients

June 30, 2020

Price of the drug to treat hospitalized patients revealed.

FDA okays novel breast, colorectal cancer treatments

June 30, 2020

Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.

Top 3 drugs to watch in second half 2020

June 23, 2020

These are the top 3 drugs recently approved — or soon to be approved by FDA — to watch in 2020.

Pharma maker seeks fast approval of lymphoma treatment

June 23, 2020

Investigational treatment will target marginal zone lymphoma (MZL) and follicular lymphoma (FL).